Thalidomide and bortezomib overcome the prognostic significance of proliferative index in multiple myeloma.

Minarik, J

Thalidomide and bortezomib overcome the prognostic significance of proliferative index in multiple myeloma. [electronic resource] - Neoplasma 2010 - 8-14 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0028-2685

10.4149/neo_2010_01_008 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Agents--therapeutic use
Boronic Acids--therapeutic use
Bortezomib
Cell Proliferation
Female
Humans
Male
Middle Aged
Multiple Myeloma--drug therapy
Plasma Cells--pathology
Prognosis
Pyrazines--therapeutic use
Thalidomide--therapeutic use